Predictive models and correlates of protection for testing biodefence vaccines. - Wikidata - thesis-toulmin - TriplyDB

Predictive models and correlates of protection for testing biodefence vaccines.

Predictive models and correlates of protection for testing biodefence vaccines.

http://www.wikidata.org/entity/Q37745002

about

Protecting against plague: towards a next-generation vaccine Approaches to modelling the human immune response in transition of candidates from research to development.Tularemia vaccines: recent developments and remaining hurdles.TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.Anthrax vaccines: present status and future prospects.Selection of Neospora caninum antigens stimulating bovine CD4+ve T cell responses through immuno-potency screening and proteomic approaches.Plague vaccines: current developments and future perspectives.The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.

P2860

Q26823422-653B46AC-FE6C-4B5B-8A14-E71851664BE7 Q33661296-D5A52C57-A16E-4623-8E17-4449A68A9AC0 Q34180914-B475CE36-E02A-40B9-9087-88CD953F99EB Q34380204-6210CFA2-9AAA-4458-8E50-472DCF8C8C65 Q38132268-6F75F7C0-9B1D-4527-B2A2-609A61CA57B7 Q38322547-1ECBEB6A-0138-4C45-9D51-B2EF4F99233E Q38514208-E76261CE-BA8D-4229-99A4-75E13C24E029 Q38589273-CBE0F950-9A67-4C1A-896B-311C75BBBC7D Q46281229-BCD02C2B-02E4-410D-AA7F-5E584B0C176F

P2860

Predictive models and correlates of protection for testing biodefence vaccines.

http://www.wikidata.org/entity/Q37745002

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictive models and correlates of protection for testing biodefence vaccines.

@en

Predictive models and correlates of protection for testing biodefence vaccines.

@nl

type

label

Predictive models and correlates of protection for testing biodefence vaccines.

@en

Predictive models and correlates of protection for testing biodefence vaccines.

@nl

prefLabel

Predictive models and correlates of protection for testing biodefence vaccines.

@en

Predictive models and correlates of protection for testing biodefence vaccines.

@nl

P1433

Q37745002-AD19D38E-E029-4C9B-8E06-3754DD4224F3

P1476

Q37745002-BD44C893-B286-48A9-8BED-0363295BFC1C

P2093

Q37745002-1C9C37A7-13B4-407A-93AD-A502EC18DA7F

Q37745002-60EF313F-9E47-47C8-859F-7933AE1BB9F3

Q37745002-FC24A10A-299A-400C-8B15-2DCAEE24D329

P2860

Q37745002-050EC902-CB44-4F07-AB53-64304ECE1F26

Q37745002-0C4C2407-CBF0-4F0E-95B0-6C4801658A0C

Q37745002-0CCFF7A5-971D-4064-8E46-E3DA47950E66

Q37745002-0ECBDA46-1996-4B73-AF00-29A54265A22F

Q37745002-115DE035-9921-4C22-87A2-153D9E5A77AB

Q37745002-14E04729-F402-4CD0-80A1-6C1FD142EC63

Q37745002-15C9D4B0-5839-4549-87BA-BF94A96D3BEA

Q37745002-1F79FDB1-F591-41E8-AF37-A83E331C8FF1

Q37745002-23F4BFB7-4898-4D8D-9441-65A50282E743

Q37745002-25D23346-39AC-4294-961A-C0FC86BAFAF1

P304

Q37745002-2F20AD18-254E-4EF7-85E9-91202FF889CD

P31

Q37745002-65EC32F3-675E-4CF2-B795-51BC9C50B71F

P356

Q37745002-3457C67D-C05C-433E-88DB-6AE8808DD5EC

P433

Q37745002-BA647B3A-61B9-4E46-921B-CC5E75880C72

P478

Q37745002-EB8487CD-0A19-4F45-BB2F-7415C203ABC2

P577

Q37745002-0B8B2082-4E6C-47A9-8A37-4BE7A5CD2B6F

P698

Q37745002-D009DD93-CA73-4255-9853-47AAB3874398

P356

P1433

Expert Review of Vaccines

P1476

Predictive models and correlates of protection for testing biodefence vaccines.

@en

P2093

E Diane Williamson

http://www.w3.org/2001/XMLSchema#string

M G Duchars

http://www.w3.org/2001/XMLSchema#string

Robert Kohberger

http://www.w3.org/2001/XMLSchema#string

P2860

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax

Animal models in influenza vaccine testing.

Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality

Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei.

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.

P304

527-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.10.22

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20450327

http://www.w3.org/2001/XMLSchema#string